{"bill":{"bill_id":1380404,"change_hash":"577a359d2771988918e38e83dd9f5542","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HB8588\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/8588\/all-info","completed":0,"status":1,"status_date":"2020-10-13","progress":[{"date":"2020-10-13","event":1},{"date":"2020-10-13","event":9},{"date":"2020-10-13","event":9}],"state":"US","state_id":52,"bill_number":"HB8588","bill_type":"B","bill_type_id":"1","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"Improving the American Drug Supply Chain Act of 2020","description":"Requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) study the current and historical production of drugs and key ingredients in the United States and in foreign countries, and (2) formulate recommendations for promoting increased production of drugs and key ingredients in the United States.","pending_committee_id":2302,"committee":{"committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"},"referrals":[{"date":"2020-10-13","committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"}],"history":[{"date":"2020-10-13","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2020-10-13","action":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","chamber":"H","chamber_id":114,"importance":1},{"date":"2020-10-13","action":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","chamber":"H","chamber_id":114,"importance":1}],"sponsors":[{"people_id":14084,"person_hash":"lqvkdn2d","party_id":"2","state_id":52,"party":"R","role_id":1,"role":"Rep","name":"Richard Hudson","first_name":"Richard","middle_name":"","last_name":"Hudson","suffix":"","nickname":"","district":"HD-NC-8","ftm_eid":6611759,"votesmart_id":136448,"opensecrets_id":"N00033630","knowwho_pid":161542,"ballotpedia":"Richard_Hudson","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":18292,"person_hash":"c8kj8aoc","party_id":"1","state_id":52,"party":"D","role_id":1,"role":"Rep","name":"Lisa Rochester","first_name":"Lisa","middle_name":"Blunt","last_name":"Rochester","suffix":"","nickname":"","district":"HD-DE","ftm_eid":38420440,"votesmart_id":173249,"opensecrets_id":"N00038414","knowwho_pid":558891,"ballotpedia":"Lisa_Blunt_Rochester","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":8,"type":"Related","sast_bill_number":"HB14","sast_bill_id":1381253}],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13146,"subject_name":"Congressional oversight"},{"subject_id":13593,"subject_name":"Drug safety, medical device, and laboratory regulation"},{"subject_id":13169,"subject_name":"Economic performance and conditions"},{"subject_id":13308,"subject_name":"Emergency medical services and trauma care"},{"subject_id":13472,"subject_name":"Emergency planning and evacuation"},{"subject_id":22688,"subject_name":"Government studies and investigations"},{"subject_id":13206,"subject_name":"Health care costs and insurance"},{"subject_id":13214,"subject_name":"Health technology, devices, supplies"},{"subject_id":13614,"subject_name":"Intellectual property"},{"subject_id":323150,"subject_name":"Labor market"},{"subject_id":13701,"subject_name":"Manufacturing"},{"subject_id":13490,"subject_name":"Prescription drugs"}],"texts":[{"doc_id":2214083,"date":"2020-11-05","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HB8588\/id\/2214083","state_link":"https:\/\/www.congress.gov\/116\/bills\/hr8588\/BILLS-116hr8588ih.pdf","text_size":298162,"text_hash":"a586511ee53420e8067acec37def5d0b"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}